Search
10X Genomics Inc
TXGAdd to Watchlist
59.160USD
+0.590+1.01%
Market hours （ET）Quotes delayed by 15 min
7.71BMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-10The current earnings forecast score of 10X Genomics Inc is 7.25, ranking 142 out of 200 in the Healthcare Equipment & Supplies industry. The average price target is 16.00, with a high of 20.00 and a low of 14.00.
Analyst Rating
Based on
16
analysts
Buy
Current Rating
44.923
Target Price
-13.66%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
10X Genomics Inc
TXG
16
Stryker Corp
SYK
30
Medtronic PLC
MDT
30
Dexcom Inc
DXCM
30
Zimmer Biomet Holdings Inc
ZBH
29
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is 10X Genomics Inc's expected revenue for the next quarter?
10X Genomics Inc's expected revenue is 147.24M.
What is 10X Genomics Inc's price target?
Analysts forecast that 10X Genomics Inc's price target is USD 16.00, with the highest forecast at USD 20.00 and the lowest forecast at USD 14.00.
How have 10X Genomics IncTXG's recent earnings per share performed?
The market expectation was USD -0.14, while 10X Genomics IncTXG's earnings per share (EPS) for the previous quarter was USD -0.10. EPS for the next quarter is expected at USD -0.25.
What is the analyst rating for 10X Genomics Inc?
Based on the ratings of 10X Genomics Inc's stock from 16 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.